These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 35088297)
1. Does Maternal Incarceration Impact Infants with Neonatal Abstinence Syndrome? Drago MJ; Shabanova V; Hochreiter D; Grossman M; Mercurio M Matern Child Health J; 2022 May; 26(5):1095-1103. PubMed ID: 35088297 [TBL] [Abstract][Full Text] [Related]
2. Comparison of Safety and Efficacy of Methadone vs Morphine for Treatment of Neonatal Abstinence Syndrome: A Randomized Clinical Trial. Davis JM; Shenberger J; Terrin N; Breeze JL; Hudak M; Wachman EM; Marro P; Oliveira EL; Harvey-Wilkes K; Czynski A; Engelhardt B; D'Apolito K; Bogen D; Lester B JAMA Pediatr; 2018 Aug; 172(8):741-748. PubMed ID: 29913015 [TBL] [Abstract][Full Text] [Related]
3. Treating Neonatal Abstinence Syndrome in a Rural Hospital: Lessons Learned. Gadomski A; Riley M; Ramiza K; Onofrey L; Zinkievich R; Krupa N; Scribani M Acad Pediatr; 2018; 18(4):425-429. PubMed ID: 29428413 [TBL] [Abstract][Full Text] [Related]
4. Neonatal Outcomes after Medications for Opioid Use Disorder during Pregnancy in a State Women's Prison Facility, 2016-2019. Knittel AK; Swartzwelder RA; Zarnick S; Tsujimoto TM; Horne T; Lin FC; Edwards J; Amos E; Alexander J; Thorp J; Jones HE J Addict Med; 2023 Sep-Oct 01; 17(5):587-591. PubMed ID: 37788614 [TBL] [Abstract][Full Text] [Related]
6. The relationship between gestational age and the severity of neonatal abstinence syndrome. Gibson KS; Stark S; Kumar D; Bailit JL Addiction; 2017 Apr; 112(4):711-716. PubMed ID: 27886650 [TBL] [Abstract][Full Text] [Related]
7. Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy. O'Connor AB; Collett A; Alto WA; O'Brien LM J Midwifery Womens Health; 2013; 58(4):383-8. PubMed ID: 23931660 [TBL] [Abstract][Full Text] [Related]
8. Neonatal Abstinence Syndrome Severity Index Predicts 18-Month Neurodevelopmental Outcome in Neonates Randomized to Morphine or Methadone. Flannery T; Davis JM; Czynski AJ; Dansereau LM; Oliveira EL; Camardo SA; Lester BM J Pediatr; 2020 Dec; 227():101-107.e1. PubMed ID: 32805259 [TBL] [Abstract][Full Text] [Related]
9. Maternal and infant outcomes following third trimester exposure to marijuana in opioid dependent pregnant women maintained on buprenorphine. O'Connor AB; Kelly BK; O'Brien LM Drug Alcohol Depend; 2017 Nov; 180():200-203. PubMed ID: 28917206 [TBL] [Abstract][Full Text] [Related]
10. Opioid Utilization by Pregnant Women with Sickle Cell Disease and the Risk of Neonatal Abstinence Syndrome. Nnoli A; Seligman NS; Dysart K; Baxter JK; Ballas SK J Natl Med Assoc; 2018 Apr; 110(2):163-168. PubMed ID: 29580450 [TBL] [Abstract][Full Text] [Related]
11. The Alberta Neonatal Abstinence Syndrome Mother-Baby Care ImprovEmeNT (NASCENT) program: protocol for a stepped wedge cluster randomized trial of a hospital-level Neonatal Abstinence Syndrome rooming-in intervention. Wine O; McNeil D; Kromm SK; Foss K; Caine V; Clarke D; Day N; Johnson DW; Rittenbach K; Wood S; Hicks M BMC Health Serv Res; 2023 May; 23(1):448. PubMed ID: 37149626 [TBL] [Abstract][Full Text] [Related]
12. Maternal opioid dose is associated with neonatal abstinence syndrome in children born to women with sickle cell disease. Shirel T; Hubler CP; Shah R; Mager AB; Koch KL; Sheth D; Uhing MR; Jones CW; Field JJ Am J Hematol; 2016 Jun; 91(4):416-9. PubMed ID: 26799428 [TBL] [Abstract][Full Text] [Related]
13. Maternal opioid exposure, neonatal abstinence syndrome, and infant healthcare utilization: A retrospective cohort analysis. Ko JY; Yoon J; Tong VT; Haight SC; Patel R; Rockhill KM; Luck J; Shapiro-Mendoza C Drug Alcohol Depend; 2021 Jun; 223():108704. PubMed ID: 33894458 [TBL] [Abstract][Full Text] [Related]
14. Could prenatal food insecurity influence neonatal abstinence syndrome severity? Rose-Jacobs R; Trevino-Talbot M; Lloyd-Travaglini C; Cabral HJ; Vibbert M; Saia K; Wachman EM Addiction; 2019 Feb; 114(2):337-343. PubMed ID: 30422365 [TBL] [Abstract][Full Text] [Related]
15. Length of Stay Among Infants with Neonatal Abstinence Syndrome and Risk of Hospital Readmission. Diop H; Cui X; Nielsen T; Peacock-Chambers E; Gupta M Matern Child Health J; 2022 Oct; 26(10):2020-2029. PubMed ID: 35907127 [TBL] [Abstract][Full Text] [Related]
16. Differences in the profile of neonatal abstinence syndrome signs in methadone- versus buprenorphine-exposed neonates. Gaalema DE; Scott TL; Heil SH; Coyle MG; Kaltenbach K; Badger GJ; Arria AM; Stine SM; Martin PR; Jones HE Addiction; 2012 Nov; 107 Suppl 1(0 1):53-62. PubMed ID: 23106927 [TBL] [Abstract][Full Text] [Related]
17. Neonatal Abstinence Syndrome among Infants Born to Mothers with Sickle Cell Hemoglobinopathies. Brown JA; Sinkey RG; Steffensen TS; Louis-Jacques AF; Louis JM Am J Perinatol; 2020 Feb; 37(3):326-332. PubMed ID: 31756755 [TBL] [Abstract][Full Text] [Related]
18. Antenatal methadone vs buprenorphine exposure and length of hospital stay in infants admitted to the intensive care unit with neonatal abstinence syndrome. Tolia VN; Murthy K; Bennett MM; Miller ES; Benjamin DK; Smith PB; Clark RH J Perinatol; 2018 Jan; 38(1):75-79. PubMed ID: 29048415 [TBL] [Abstract][Full Text] [Related]
19. Long-term mortality in mothers of infants with neonatal abstinence syndrome: A population-based parallel-cohort study in England and Ontario, Canada. Guttmann A; Blackburn R; Amartey A; Zhou L; Wijlaars L; Saunders N; Harron K; Chiu M; Gilbert R PLoS Med; 2019 Nov; 16(11):e1002974. PubMed ID: 31770382 [TBL] [Abstract][Full Text] [Related]
20. Morphine vs Methadone Treatment for Infants with Neonatal Abstinence Syndrome. Tolia VN; Murthy K; Bennett MM; Greenberg RG; Benjamin DK; Smith PB; Clark RH J Pediatr; 2018 Dec; 203():185-189. PubMed ID: 30220442 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]